Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Income from Continuing Operations (2016 - 2025)

PAVmed has reported Income from Continuing Operations over the past 5 years, most recently at 2757000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 341.42% year-over-year to 2757000.0; the TTM value through Dec 2025 reached 2469000.0, up 95.03%, while the annual FY2025 figure was 2469000.0, 108.69% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 2757000.0 at PAVmed, up from 6011000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 18623000.0 in Q1 2025 and troughed at 29932000.0 in Q3 2022.
  • A 5-year average of 14388526.32 and a median of 17408000.0 in 2023 define the central range for Income from Continuing Operations.
  • On a YoY basis, Income from Continuing Operations climbed as much as 200.6% in 2025 and fell as far as 341.42% in 2025.
  • Year by year, Income from Continuing Operations stood at 19679000.0 in 2021, then dropped by 24.86% to 24572000.0 in 2022, then increased by 29.16% to 17408000.0 in 2023, then skyrocketed by 106.56% to 1142000.0 in 2024, then tumbled by 341.42% to 2757000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for PAVM at 2757000.0 in Q4 2025, 6011000.0 in Q3 2025, and 12324000.0 in Q2 2025.